ISMRC 2023 Final Programme

7 Host Institute of Tumor Biology University Medical Center Hamburg-Eppendorf The ITB was founded in 2002 to bridge between basic research and the clinic. Translational research conducted in our laboratory aims at a better understanding of the molecular mechanisms underly- ing cancer development and progres- sion, improved cancer diagnostics and also treatment of cancer patients, with a particular emphasis on so called ‘targeted therapies’. Research at ITB contributed significantly to an improvement of can- cer diagnostics of a variety of cancers by, for example, the development of blood diagnostic tests (‘liquid biopsy’) and by identification and characterization of no- vel biomarkers for certain cancer types. Institute of Tumor Biology University Medical Center Hamburg-Eppendorf Martinistrasse 52 Building N27 20246 Hamburg | Germany Co-Host European Liquid Biopsy Society With the start of 2020, the European Li- quid Biopsy Society (ELBS) was establis- hed by the initiative of Prof. Klaus Pan- tel, physician and tumor biologist at the University hospital Hamburg-Eppendorf (UKE). Academic partner institutions and partners from industry (SME as well as large diagnostic and pharma companies) want to jointly promote research around liquid biopsy and its use in clinical practi- ce. ELBS is open to attract new partners and will be a hub for liquid biopsy re- search in Europe with the key goal to translate liquid biopsy assays into clinical practice for the benefit of patients. Conference and Exhibition Organizer Hanser & Co GmbH Zum Ehrenhain 34 22885 Barsbüttel | Germany Tel.: +49 40 670882-0 ismrc@cpo-hanser.de Symposium Organisation